AGP Picks
View all

AGP Executive Report

Last update: an hour ago

Health Oversight: Guinea-Bissau’s health minister says the government has not approved a proposed hepatitis B study involving newborns, despite reports that a revised plan had received ethics approval in Denmark. He said research involving children must meet national law and international standards. Election Transition: The December 6 election is in doubt: the prime minister and electoral commission say conditions are not in place for voting. ECOWAS is pressing the junta to begin talks, as scrutiny grows over its promise to restore civilian rule. Maritime Incident: The Guinea-Bissau-flagged cargo ship HS Dignity sank after a drone strike off Bulgaria. Eleven crew members were missing; Bulgaria said Russia may be behind the attacks but acknowledged it has no proof.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 13, 2026

Stand Up for Science pushes Congress to halt CDC vaccine study in Guinea-Bissau

AGP

fallback image
Oct. 8, 2026

Stand Up for Science blasts CDC plan to revive Guinea-Bissau vaccine study

AGP

fallback image
Aug. 21, 2026

Senegal’s president backs MSGBC Oil, Gas & Power 2026 in Dakar

AGP

fallback image
Jul. 2, 2026

Stationed at Home expands to 40-plus international territories

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns

Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns


fallback image
Oct. 8, 2026

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Sep. 11, 2026

UM holds International Night to promote international exchange

Macao Government News

fallback image
Oct. 13, 2026

Stand Up for Science Launches Petition to Halt CDC Vaccine Study in West Africa

EIN Presswire

fallback image
Sep. 4, 2026

Đurić Confers with Guinea-Bissau’s Minister of Foreign Affairs

Ministry of Foreign Affairs of the Republic of Serbia

fallback image
Sep. 2, 2026

Đurić Confers with Guinea-Bissau’s Minister of Foreign Affairs

Ministry of Foreign Affairs of the Republic of Serbia

fallback image
Oct. 12, 2026

Countries locked into IMF austerity programs are also around twice as vulnerable to economic fallout from war against Iran

Oxfam

More press releases

Video Stories

YouTube video thumbnail:  Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
Play
Controversial US-Backed Hepatitis B Vaccine Trial to Move Forward in Guinea-Bissau
YouTube video thumbnail:  Centre Showcasing Black and African Culture Opens in London
Play
Centre Showcasing Black and African Culture Opens in London
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail:  Fearing Ebola, Mothers and Children in DRC Skip Vital Care
Play
Fearing Ebola, Mothers and Children in DRC Skip Vital Care
YouTube video thumbnail:  Rwanda and the EU: Who Benefits From Deportation Deals?
Play
Rwanda and the EU: Who Benefits From Deportation Deals?

Video Title

Sign up for:

Bissau Political News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Bissau Political News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.